Research study Program year 2025 Source: CMS Open Payments

M16-283 - Long-Term Safety Study of Elagolix in Combination With Estradiol Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Research payments

$84,600

15 payments

Through program year 2025, $84,600 in research payments was reported against M16-283 - Long-Term Safety Study of Elagolix in Combination With Estradiol Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women, across 15 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$84,600	15

Breakdown

Who paid Research payments · program year 2025

AbbVie, Inc. $84,600 15 payments

Who received the money Research payments · program year 2025

University Of Texas Southwestern Medical Organisation paid for research $50,304 1 payment
James A Simon MD Pc Organisation paid for research $7,787 4 payments
Columbia University Medical Center Organisation paid for research $6,750 1 payment
Agile Clinical Research Trials LLC Organisation paid for research $6,000 2 payments
Millennium Clinical Trials LLC Organisation paid for research $5,500 1 payment
Bayview Research Group Organisation paid for research $4,000 1 payment
Clinical Research Partners LLC Organisation paid for research $2,359 2 payments
Advances In Health INC Organisation paid for research $1,000 1 payment
Dct- Hcwc LLC Dba Discovery Clinical Trials Organisation paid for research $900 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.